There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Arvinas Holding Company (ARVN – Research Report), Eledon Pharmaceuticals (ELDN – Research Report) and Agenus (AGEN – Research Report) with bullish sentiments.
Arvinas Holding Company (ARVN)
In a report released today, Robert Driscoll from Wedbush initiated coverage with a Buy rating on Arvinas Holding Company and a price target of $57.00. The company’s shares closed last Tuesday at $34.33.
According to TipRanks.com, Driscoll is a 4-star analyst with an average return of
Currently, the analyst consensus on Arvinas Holding Company is a Strong Buy with an average price target of $66.92, which is a 106.6% upside from current levels. In a report released today, Barclays also maintained a Buy rating on the stock with a $60.00 price target.
See the top stocks recommended by analysts >>
Eledon Pharmaceuticals (ELDN)
Noble Financial analyst Robert LeBoyer reiterated a Buy rating on Eledon Pharmaceuticals today and set a price target of $10.00. The company’s shares closed last Tuesday at $2.26.
According to TipRanks.com, LeBoyer is currently ranked with 0 stars on a 0-5 stars ranking scale, with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Eledon Pharmaceuticals with a $16.20 average price target, which is a 653.5% upside from current levels. In a report released yesterday, H.C. Wainwright also reiterated a Buy rating on the stock with a $16.00 price target.
Agenus (AGEN)
In a report released today, Mayank Mamtani from B.Riley Financial reiterated a Buy rating on Agenus, with a price target of $42.00. The company’s shares closed last Tuesday at $12.01.
According to TipRanks.com, Mamtani has 0 stars on 0-5 stars ranking scale with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Agenus with a $39.00 average price target, which is a 213.3% upside from current levels. In a report released yesterday, H.C. Wainwright also maintained a Buy rating on the stock with a $40.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on ARVN:
